2nd Edition of Cell & Gene Therapy World Conference(CGTWC) 2026

Scientific Sessions

CRISPR Cas9 and Beyond: Emerging Genome Editing Platforms

This worldwide meeting brings together the world's leading scientists, researchers, and innovators to present the newest and best developments in genetic medicine.

The primary focus area is "CRISPR-Cas9 & Beyond: Emerging Genome Editing Platforms," referring to these high-tech tools that can allow for accurate and precise modifications to the DNA in order to repair genetic defects, increase resistance to disease, and discover new therapeutic tools. These emerging genome editing tool platforms reach beyond traditional CRISPR methods and will allow for greater precision, efficiency, and the creation of novel therapeutics.

Related Sessions

CRISPR Cas9 and Beyond: Emerging Genome Editing Platforms
Precision Genome Editing: From Target Discovery to Clinical Application
Engineering the Immune System: Gene and Cell Based Modulation
Non Viral Gene Delivery Strategies: Safety, Scalability, and Translation
Stem Cell Derived Therapeutics: iPSCs, Organoids and Tissue Engineering
Allogeneic vs Autologous Cell Therapies: Manufacturing, Efficacy, and Access
Manufacturing for Personalized Medicine: Customised Cell Products at Scale
Analytics, Potency Assays, and Rapid Release Strategies
CGTs for Monogenic Disorders: Delivering the Cure
Gene and Cell Therapies in Oncology: CAR T, NK, TCR, Oncolytic Approaches
Neurological and Neurodegenerative Disease Applications of CGTs
Market Access, Health Economics, and Reimbursement in CGT
Global Access and Equity: Bridging the CGT Innovation Gap
The Future Landscape of Cell and Gene Therapies: 2030 and Beyond
Cell and Gene Therapy Clinical Development
Cell and Gene Therapy Pipeline Analysis